Researchers Reactivate Silenced Gene for Friedreich's Ataxia

Researchers at St. Jude Children's Research Hospital have successfully reactivated the frataxin gene, which is silenced in Friedreich's ataxia. Published in Nature Cell Biology, this study challenges prior assumptions about gene expression regulation by demonstrating that gene-activating proteins can overcome repressive chromatin packaging. This breakthrough offers promising new avenues for therapeutic strategies targeting genes wrongly switched off in various diseases.